Estimasi Nilai Years Lived with Disability (YLD) Terhadap Penyakit Kardiovaskular Akibat Rokok di Indonesia

https://doi.org/10.22146/farmaseutik.v1i1.60071

Nurul Faizah(1*), Susi Ari Kristina(2)

(1) Universitas Nahdlatul Ulama
(2) Fakultas Farmasi, Universitas Gadjah Mada
(*) Corresponding Author

Abstract


Merokok merupakan salah satu kekhawatiran terbesar yang dihadapi dunia kesehatan karena menyebabkan hampir 6 juta orang meninggal dalam setahun. Penelitian ini bertujuan untuk mengetahui dampak rokok terhadap penyakit kardiovaskular di Indonesia menggunakan Years Lived with Disability (YLD).

Penelitian ini merupakan studi epidemiologi dengan perspektif govermental. Pemilihanjenis penyakit kardiovaskular akibat rokok diperoleh berdasarkan nilai relative risk >1 dan ketersediaan data pada Badan Penyelenggara Jaminan Sosial (BPJS) Kesehatan. Proporsi kontribusi rokok terhadap penyakit-penyakit diestimasi dengan mengaplikasikan smoking attributable fraction (SAF) yang didapatkan dengan mengalikan hasil prevalensi merokok di Indonesia dengan relative risk. Selanjutnya estimasi YLD penyakit kardiovaskular akibat rokok dihitung berdasarkan data riil jumlah pasien yang diperoleh dari database BPJS tingkat nasional.

Nilai YLD tertinggi pada penyakit kardiovaskular akibat rokok dalam penelitian ini adalah hipertensi kemudian disusul oleh stroke, penyakit jantung iskemik dan penyakit jantung koroner.


Keywords


YLD; Kardiovaskular; BPJS; Rokok



References

Ambrose, J. A. and Barua, R. S. (2004) ‘The pathophysiology of cigarette smoking and cardiovascular disease: An update’, Journal of the American College of Cardiology, 43(10), pp. 1731–1737. doi: 10.1016/j.jacc.2003.12.047. Centers for Disease Control and Prevention (US), National Center for Chronic Disease Prevention and Health Promotion (US) and Office on Smoking and Health (US) (2010) How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US) (Publications and Reports of the Surgeon General). Available at: http://www.ncbi.nlm.nih.gov/books/NBK53017/ (Accessed: 23 September 2020). Do, Y. K. et al. (2004) ‘Disability weights for the korean burden of disease study: focused on comparison with disability weights in the Australian burden of disease study’, Journal of Preventive Medicine and Public Health = Yebang Uihakhoe Chi, 37(1), pp. 59–71. Ezzati Majid et al. (2005) ‘Role of Smoking in Global and Regional Cardiovascular Mortality’, Circulation, 112(4), pp. 489–497. doi: 10.1161/CIRCULATIONAHA.104.521708. Pérez-Ríos, M. and Montes, A. (2008) ‘Methodologies used to estimate tobacco-attributable mortality: a review’, BMC Public Health, 8, p. 22. doi: 10.1186/1471-2458-8-22. R, S. and G, B. (1989) ‘Meta-analysis of relation between cigarette smoking and stroke.’, BMJ (Clinical Research ed.), 298(6676), pp. 789–794. doi: 10.1136/bmj.298.6676.789. Samet, J. M. (2010) ‘Estimating the burden of smoking: premature mortality, morbidity, and costs’, Salud Publica De Mexico, 52 Suppl 2, pp. S98-107. doi: 10.1590/s0036-36342010000800005. World Health Organization (ed.) (2009) Global health risks: mortality and burden of disease attributable to selected major risks. Geneva, Switzerland: World Health Organization. Yang, M. C. et al. (2005) ‘Smoking attributable medical expenditures, years of potential life lost, and the cost of premature death in Taiwan’, Tobacco Control, 14 Suppl 1, pp. i62-70. doi: 10.1136/tc.2004.007963.



DOI: https://doi.org/10.22146/farmaseutik.v1i1.60071

Article Metrics

Abstract views : 460

Refbacks



Majalah Farmaseutik Indexed by:

   
 
 
Creative Commons License